<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">All potent SARS-CoV-2 M
 <sup>pro</sup> inhibitors contain reactive warheads such as α-ketoamide (boceprevir (
 <bold>28</bold>), calpain inhibitor XII (
 <bold>62</bold>)) or aldehyde (MG-132 (
 <bold>43</bold>), calpain inhibitor II (
 <bold>61</bold>)) or aldehyde prodrug, the bisulfite (GC-376 (
 <bold>64</bold>)). This result suggests that reactive warheads might be essential for SARS-CoV-2 M
 <sup>pro</sup> inhibition. The compounds identified in this study represent some of the most potent and selective hits reported so far, and have similar activity to the recently reported SARS-CoV-2 M
 <sup>pro</sup> inhibitors (
 <bold>ebselen</bold>, 
 <bold>N3</bold>, and 
 <bold>13b</bold>) (Table 
 <xref rid="Tab3" ref-type="table">3</xref>). Calpain inhibitor XII (
 <bold>62</bold>) had similar potency to the recently disclosed compounds (
 <bold>11a</bold> and 
 <bold>11b</bold>) (Table 
 <xref rid="Tab3" ref-type="table">3</xref>).
 <sup>
  <xref ref-type="bibr" rid="CR11">11</xref>
 </sup> Notably, boceprevir (
 <bold>28</bold>), calpain inhibitor II (
 <bold>61</bold>) and XII (
 <bold>62</bold>) have different chemical scaffolds than the substrate mimetics GC-376 (
 <bold>64</bold>), (
 <bold>N3</bold>, 
 <bold>13b</bold>, 
 <bold>11a</bold>, and 
 <bold>11b</bold>), therefore providing new opportunities for designing more potent and selective SARS-CoV-2 M
 <sup>pro</sup> inhibitors.
</p>
